Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR

FEBS Lett. 2004 Feb 13;559(1-3):171-4. doi: 10.1016/S0014-5793(04)00059-6.

Abstract

p53 exerts its tumor suppressor activity through both transcription-dependent and transcription-independent processes. Although the transcription-dependent activity of p53 has been extensively studied, the mechanism for transcription-independent p53-mediated tumor suppression is less well known. Recently, it was reported that p53 can directly induce mitochondrial permeabilization and promote apoptosis. This occurs through complexation of the DNA-binding region of p53 with the anti-apoptotic proteins Bcl-x(L) and Bcl-2 (Mihara, M. et al. (2003) Mol. Cell 11, 577-590). Using nuclear magnetic resonance (NMR) spectroscopy we show that the interaction surface on p53 involves the same region that is used by the protein to contact DNA. The p53-binding site on Bcl-x(L) consists of the carboxy-terminus of the first alpha-helix, the loop between alpha3 and alpha4, and the loop between alpha5 and alpha6 of Bcl-x(L). Furthermore, the interaction of p53 with Bcl-x(L) is blocked by the binding of a 25-residue peptide derived from the BH3 region of the pro-apoptotic protein referred to as Bad.

MeSH terms

  • Binding Sites
  • Carrier Proteins / chemistry
  • DNA, Complementary / chemistry
  • DNA, Complementary / metabolism
  • Gene Library
  • Humans
  • Models, Molecular
  • Nuclear Magnetic Resonance, Biomolecular / methods*
  • Peptide Fragments / pharmacology
  • Tumor Suppressor Protein p53 / chemistry*
  • Tumor Suppressor Protein p53 / metabolism
  • bcl-Associated Death Protein

Substances

  • BAD protein, human
  • Carrier Proteins
  • DNA, Complementary
  • Peptide Fragments
  • Tumor Suppressor Protein p53
  • bcl-Associated Death Protein